Pegvisomant, developed by professor John Kopchick in 1987, shows potential to make treatment-resistant lung cancer cells more ...
Zacks Investment Research on MSN
GSK's Risvutatug Rezetecan gets Japan orphan drug tag for lung cancer
GSK plc GSK announced that Japan’s Ministry of Health, Labour and Welfare has granted Orphan Drug Designation (ODD) to ...
New research from the University of Virginia shows people who have serious cases of COVID or influenza face another risk ...
Welltica+ on MSN
Possible link between severe COVID-19 and lung cancer risk
A new study suggests that a severe bout of COVID-19 or flu could leave long-term changes in the lungs that may increase ...
Lung cancer used to have grim outcomes but earlier detection is improving those odds. A new combined procedure with diagnosis and removal using two different robotic systems at Roper could change that ...
Severe covid and flu infections may raise the risk of developing lung cancer years later, researchers at the University of ...
According to the American Lung Association, the national five-year lung cancer survival rate is about 29.7 percent. The ...
Dr. Brian S. Henick, a medical oncologist at Columbia University Irving Medical Center and director of the phase 1 program ...
The 2026 IASLC Targeted Therapies in Lung Cancer meeting brought together leading oncologists, surgeons, and patient ...
Fast-growing lung cancer risk factors include smoking, male sex, and solid nodules on CT. Learn more about identifying ...
A mobile lung screening unit designed to give patients a better chance by detecting cancer early, has seen about 3,000 people ...
Mel McLaughlin and her late sister were both nonsmokers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results